Investigational Drug Information for HSK3486
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug HSK3486?
HSK3486 is an investigational drug.
There have been 28 clinical trials for HSK3486. The most recent clinical trial was a Phase 3 trial, which was initiated on December 8th 2020.
The most common disease conditions in clinical trials are Depressive Disorder, Liver Diseases, and Renal Insufficiency, Chronic. The leading clinical trial sponsors are Sichuan Haisco Pharmaceutical Group Co., Ltd., Sichuan Haisco Pharmaceutical Group Co., Ltd, and Haisco-USA Pharmaceuticals, Inc.
There are two US patents protecting this investigational drug and thirty-seven international patents.
Summary for HSK3486
|US Patent Applications||4|
|WIPO Patent Applications||9|
|Japanese Patent Applications||3|
|Clinical Trial Progress||Phase 3 (2020-12-08)|
Recent Clinical Trials for HSK3486
|Safety and Efficacy of HSK3486 Compares to Propofol for Induction of General Anesthesia in Adults With Elective Surgery||Haisco-USA Pharmaceuticals, Inc.||Phase 3|
|Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users||Haisco-USA Pharmaceuticals, Inc.||Phase 1|
|Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia||Haisco-USA Pharmaceuticals, Inc.||Phase 3|
Clinical Trial Summary for HSK3486
Top disease conditions for HSK3486
Top clinical trial sponsors for HSK3486
US Patents for HSK3486
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|HSK3486||See Plans and Pricing||Use of GABAA receptor reinforcing agent in preparation of sedative and anesthetic medicament||HAISCO CHENGDU PHARMACEUTICAL TECHNOLOGY CO., LTD. (Chengdu, Sichuan, CN)||See Plans and Pricing|
|HSK3486||See Plans and Pricing||Phenol derivative and preparation method and use in medicine thereof||Sichuan Haisco Pharmaceutical Co., Ltd. (Chengdu, CN)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
International Patents for HSK3486
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|HSK3486||Australia||AU2015311394||2034-09-04||See Plans and Pricing|
|HSK3486||Brazil||BR112017004448||2034-09-04||See Plans and Pricing|
|HSK3486||Canada||CA2959812||2034-09-04||See Plans and Pricing|
|HSK3486||China||CN105579034||2034-09-04||See Plans and Pricing|
|HSK3486||Eurasian Patent Organization||EA035649||2034-09-04||See Plans and Pricing|
|HSK3486||Eurasian Patent Organization||EA201790525||2034-09-04||See Plans and Pricing|
|HSK3486||European Patent Office||EP3189834||2034-09-04||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|